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Aim: This study aimed to cross-culturally translate and adapt the Cardiac Self-Efficacy 
Questionnaire into Arabic and subsequently evaluate the psychometric properties of 
that translation in a population of Arabic patients. Method: The original English version 
of the Cardiac Self-Efficacy Questionnaire was translated into Arabic following a 
process recommended by the World Health Organization. A convenience sample 
consisting of 268 Jordanian patients with coronary heart disease were recruited from a 
university-affiliated hospital in Amman, Jordan. Data were collected from August, 2018 
until January, 2019. The factor structure, face and content validities, and internal 
consistency of the Arabic Cardiac Self-Efficacy Questionnaire were evaluated. Results: 
The factor structure analysis supported a three-factor high-order structure of the Arabic 
Cardiac Self-Efficacy Questionnaire. Face validity showed that the language used, style 
and format were clear. The content validity demonstrated a very good content validity 
index. The reliability was good with ranging from 0.89 to 0.93 for all questionnaire 
subscales. Conclusion: The Arabic Cardiac Self-Efficacy Questionnaire is a valid and 
reliable instrument to assess the Cardiac Self-Efficacy of Arabic patients diagnosed with 
coronary heart disease. Further assessment of the psychometric properties of the 
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What is already known about this topic? 
• Globally cardiovascular diseases are the leading cause of death and increasing 
progressively. Particularly, in the Middle Eastern countries.  
• High self-efficacy level is associated with the adoption of a healthy lifestyle of 
patients with coronary heart disease.  
• There is no valid and reliable Arabic tool to measure cardiac self-efficacy among 
patients with coronary heart disease.   
 
What this paper adds:  
• The Arabic version of the cardiac self-efficacy questionnaire is valid and reliable 
instrument to assess cardiac self-efficacy level among patients with coronary 
heart disease.  
• Using Modern Standard Arabic (Fusha) during the translation and cross-cultural 
adaptation process makes the Arabic version of the cardiac self-efficacy 
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questionnaire more broadly applicable for a range of cardiac patients in Arabic 
speaking countries. 
Implications of this paper 
• Health intervention developer can use the translated version of cardiac self-
efficacy questionnaire to evaluate cardiac self-efficacy and to improve self-
management skills of patients with coronary heart disease in Arabic speaking 
countries.  
• Measuring the self-efficacy levels of Arabic speaking people using the Arabic 
CSEQ, can facilitate secondary prevention intervention measures and 
developing cardiac rehabilitation program in Arabic speaking counties. 
• The Arabic version of the cardiac self-efficacy questionnaire can be used in 
further research in future, through implementing comparisons between studies 
outcomes, in countries where there are Arabic‐speaking people. 
 
Keywords: Cardiac self-efficacy, Coronary heart disease, Cross-cultural translation, 












A Cross-Cultural Translation and Adaptation of the Arabic Cardiac Self-Efficacy 
Questionnaire for Patients with Coronary Heart Disease 
INTRODUCTION  
Self-efficacy is a psychological construct based on Bandura’s social cognitive theory 
(Bandura, 1997). Self-efficacy is an individual’s belief in his or her ability to perform a 
given task (Bandura, 1997). Patient’s self-efficacy levels are strongly associated with 
the adoption of a healthy lifestyle for Coronary Heart Disease (CHD) making it an 
important factor given that CHD is largely preventable (Köhler, Tingström, Jaarsma, & 
Nilsson, 2018; Salari et al., 2016). Several studies report disease specific self-efficacy 
as an important variable associated with positive lifestyle change in patients with 
chronic diseases such as Cardiovascular Disease (CVD); self-efficacy is associated 
with health related quality of life (Banik, Schwarzer, Knoll, Czekierda, & Luszczynska, 
2018), improvements in physical activity behaviour, dietary choices (Bergström, 
Börjesson, & Schmidt, 2015; Sharp & Salyer, 2012) and smoking abstinence (Berndt et 
al., 2013). Moreover, people with low levels of self-efficacy are less likely to adopt a 
healthy lifestyle (Sol, van der Graaf, van Petersen, & Visseren, 2011) and suffer 
adverse health outcomes such as readmission, poor mental and physical health (O’Neil, 
Berk, Davis, & Stafford, 2013). Cardiac self-efficacy has been used as useful tool to 
cardiac events (O’Neil et al., 2013) among patients with CHD. In addition, Fors and his 
colleges (2015) have found that cardiac self-efficacy is a useful tool to promote person-
centred care in clinical practice.   
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CVDs are the leading cause of death worldwide (WHO, 2015); almost 30% of all deaths 
worldwide were caused by CVD in 2015. In the Middle East there is an especially high 
prevalence of CVD (Gehani et al., 2014) and associated cardiovascular risk factors 
(Afshin et al., 2015). Coronary risk factors are likely to increase unless people adopt a 
healthy lifestyle to reduce (Crouch, Wilson, & Newbury, 2011; Saleh et al., 2015). An 
understanding of self-efficacy levels and interventions which can increase this construct 
to support healthy lifestyle change in people diagnosed, or at risk of developing CHD, 
have the potential to play an important role in prevention and the reduction of CVD rates 
in the Middle East population.  
The cardiac self-efficacy questionnaire (CSEQ) is a disease specific self-efficacy 
instrument developed by Sullivan, LaCroix, Russo, and Katon (1998) for use in patients 
with CHD undergoing cardiac catheterisation. The scale measures cardiac patients’ 
self-reported self-efficacy to make lifestyle change and manage medications in daily life 
situations. Whilst the CSEQ has previously been culturally adapted and translated into 
Swedish (Fors, Ulin, et al., 2015), Thai (Saengsiri, Thanasilp, & Preechawong, 2013), 
Korean (Kang & Yang, 2013) and Chinese  (Zhang et al., 2018). This is the first time; 
the questionnaire has been adapted to meet the needs of Arabic speaking patients. 
Therefore, the aim of this study was to translate and cross culturally adapt the CSEQ 
into Arabic to make it accessible to Middle Eastern populations and evaluate the 




This paper describes the process of translating and cross culturally adapting the 
questionnaire from its original English version into Arabic following a process of six 
steps recommended by the World Health Organization (WHO). The WHO guidelines 
provide a clear, comprehensive and systematic process for establishing cross-cultural 
adaptation of an instrument, figure 1. Moreover, the WHO process of translation and 
cross-cultural adaptation of instruments is a well-established method and has been 
refined in the course of several WHO studies. The translation and cross-cultural 
adaptation of the CSEQ achieved through precise stages of professional translation, an 
expert panel review and pre-testing of CSEQ and piloting (WHO, 2014).  
In addition, the researcher used Wild et al. (2005) guidelines and standards for the 
translation and cultural adaptation as framework for describing each step in the 
translation process: 1. Preparation; 2. Forward translation; 3. Reconciliation; 4. Back 
translation; 5. Back translation review; 6. Harmonization; 7. Cognitive debriefing; 8. 
Review of cognitive debriefing results and finalization; 9. Proofreading; and 10. Final 
report. Subsequent evaluation of the psychometric properties of the Arabic version of 
CSEQ was implemented.   
Please insert figure 1 here.  
Translation and Cross-Cultural Adaptation of the CSEQ 
The WHO process used for cross-cultural adaptation of the CSEQ consists of six steps:  
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Step One: Forward Translation: 
After obtaining a permission from the author of CSEQ. Two Jordanian translators 
implemented a detailed review and translation of the CSEQ. The first translator was a 
native Arabic speaker: a nurse familiar with self-efficacy and the care of patients with 
CHD. The second translator was a professional translator with no medical background. 
Both translators had some knowledge of English-speaking culture, and spoke fluent 
English, and their mother tongue was Arabic. The translators were instructed to use 
natural, simple, clear and acceptable language for a target sample in Jordan. The two 
translators compared the two Arabic translations; and create an initial Consensual 
Arabic Version (CAV) 1. This approach would strengthen the conceptual equivalence of 
the forward translation, avoid any ambiguity, and avoid any misunderstandings, figure 2. 
During the translation stage, the translators used Modern Standard Arabic (Fusha), 
which is a clear, concise and acceptable language for the broadest audience and 
considered as most widely used dialect in the translation of instruments into Arabic 
(Khalaila, 2013). The translators sought a conceptual equivalent of each English 
phrase, rather than conducting a verbatim translation, and took into consideration the 
definitions of the original items, questions or sentences, in order to translate them into 
the most relevant form. In addition, jargon, colloquialisms and idioms were avoided. 
Finally, they considered issues of gender applicability so; the produced translation is 
applicable for both male and female.  
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Step Two: Expert Panel – Review of the forward translation:  
 An expert panel was convened, which consisted of an additional three individuals: a 
health professional and two translators. All panel members were bilingual, figure 2. The 
panel’s aim was to review the translated version of the questionnaire and identify any 
unclear expressions, ambiguous concepts or discrepancies and to compare the forward 
translation with the original CSEQ. Any inappropriate items were rejected and 
alternative words suggested. Subsequently, the expert panel edit CAV1, then; a 
consensus of the Arabic version of the CSEQ was met and made CAV 2.  
Step Three: Back Translation into English: 
Back translation then was undertaken which involved translating the Arabic version of 
the CSEQ back into its original language (English), as a means of comparing the two 
versions (Wild et al., 2005). Two independent bilingual translators back translated the 
Arabic translation into English. The two bilingual translators, who were not involved in 
the forward translation stage, grew up in an Arabic-speaking country (Jordan) and 
completed graduate level studies in the US and UK.  None of the translators had any 
prior knowledge or experience of the original version of the questionnaire. As in the 
forward translation process, the back translation process focused on conceptual and 
cultural notions, rather than absolute linguistic equivalence. Each translator made back 
translation of CAV 2 to create English back translation version 1 (EV1) and English back 
translation version 2 (EV2). Then, the two English versions were compared to create 
Consensual English back translation Version (CBV), figure 2.   
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It is important to note that there may be some variations in the wording, as not all 
English words easily translate into other languages. For example, in the phrase 
“somewhat confident’’, the word “somewhat” does not translate easily into Arabic. The 
underlying concept of “somewhat” is “fairly”, therefore an Arabic translation should 
reflect this concept rather than search for a literal translation. The response alternative 
“Non applicable” was removed, as, after explaining at the beginning of the questionnaire 
that participants should select the most appropriate or closest answer, all items were 
considered applicable. In addition, the issue of gender in Arabic had to be considered 
during translation. Hence, words and verbs were chosen to fit both genders. This 
involved a considerable number of changes to many items in order to capture the 
original concepts. Consequently, simple and standard Arabic words were used to make 
the CSEQ clear and understandable as presented in Table 1.  
Please insert table 1 here 
Step Four:  Pre testing the CSEQ and the implementation of piloting:  
 The expert panel overseen the consensual English back translation version and the 
original CSEQ, creating final English CSEQ version, following that, the expert panel 
compared final English CSEQ version and CAV 2,  in resulting generate consensual 
Arabic version CAV 3, figure 2. After reaching CAV 3 of the CSEQ; the CAV 3 of the 
CSEQ was administered to a sample (n=10) of Jordanian patients diagnosed with CHD 
in a hospital setting. The language used in the CAV 3 of the CSEQ was suitable for a 
12-year-old child to comprehend, thus making it easily comprehensible for the study 
participants  (Beaton, Bombardier, Guillemin, & Ferraz, 2000).  
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 A pilot study, conducted by the researcher, was utilised to understand how respondents 
process and respond to CSEQ items. All participants signed Informed consent before 
joining in the study. Each participant who completed the CSEQ was interviewed in order 
to gain their feedback and ensure that all questionnaire items were understandable and 
included all the expected concepts. The interviewers asked the ten respondents the 
meaning of each item in the CSEQ; and whether they perceived any problems with the 
written language, format, or scoring scale. Participants’ feedback were documented in 
separate sheet.  
The piloting processes involved respondents completing the translated CSEQ and being 
asked for feedback on their understanding of individual questions; for example, what 
they thought the question was asking or what came to mind when they heard a 
particular phrase or term. They were asked to repeat the question in their own words, 
given associated response options, and verbalise the process they had followed when 
producing their answers. The participants were asked these questions for each item. If 
alternative words or expressions existed for an item, the respondent was asked to 
select the alternative that best represented their usual language. The researcher 
reviewed any comments made by the respondents and made any necessary revisions. 
Pre-testing was repeated until the respondents’ comments had been minimised. At the 
end of the pilot process, a final Arabic version of CSEQ was produced for future 
psychometric evaluation.   
Step Five: Final version of the CSEQ: 
The final Arabic version of the CSEQ was agreed.   
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Step Six: Documentation  
The project team developed a final version of the Arabic CSEQ and the review process 
of the CSEQ translation has been reported above. All the steps of translation and 
adaptation were successfully completed and documented. A final version of Arabic 
CSEQ is available.  
Psychometric properties evaluation   
When original CSEQ is translated into other languages, the validity and reliability of the 
items used in the original CSEQ do not always remain intact; therefore, it was 
necessary to determine psychometric properties such as validity and reliability for the 
translated CSEQ version. The psychometric properties evaluation included face and 
content validity, analysis of factor structure and the internal consistency of the Arabic 
version of CSEQ.  
Instrument   
The original CSEQ consists of 16 items divided into two sections: control symptoms (8 
items), maintain function (5 items) with an additional three items related to a healthy 
lifestyle (obesity, smoking and dietary habits), in which patients were asked to rate how 
confident they are they know on a five-point Likert scale: 0=not at all, 1=somewhat 
confident, 2=moderately confident, 3=very confident, 4=completely confident.  
The original CSEQ has been shown to be both a valid and reliable measurement tool in 
patients diagnosed with CHD (Sullivan et al., 1998). The internal consistency, as 
assessed by Cronbach’s alpha, was found to be 0.90 for control symptoms subscale 




Jordan is a small Arab country located in the Middle East. The total population of Jordan 
is 9.79 million (Department of Statistics in Jordan, 2013). Arabic is the dominant spoken 
language throughout the Middle East and North Africa. CVDs are the leading cause of 
premature death among both men and women; they account for 35%  of mortalities 
every year in Jordan (WHO, 2014). Furthermore, CHD is the main cause of death,  
representing 16.8% of total deaths (WHO, 2014).  
The study was conducted in Jordan University Hospital (JUH) in Amman, Jordan. JUH 
been established since 1971 and affiliated with Jordan University. With over 500 beds, it 
is one of the most specialized and advanced medical hospital in Amman. JUH patients 
are referral from the Ministry of Health, employees of Jordan University and their 
dependents (Ministry of Health in Jordan, 2014). Before this process was undertaken, 
permission to use and adapt the questionnaire was obtained from the author of the 
CSEQ. In addition, ethical approval was granted by Institutional review Board in JUH.   
Participants and data collection 
A convenience sample of 268 patients, diagnosed with CHD were recruited to 
participate in the psychometric testing. Data collection procedure lasted six months, 
from August, 2018 until January, 2019. Patients were eligible to be included in the study 
if they had a confirmed diagnosis of CHD, based on a positive Electrocardiograph 
(ECG) or angiographic evidence of disease.  Additional criteria included, being 
hemodynamically stable, a native Arabic speaker, over 18 years of age and possession 
of good literacy skills. Patients with severe comorbidity, cognitive impairment or drug 
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were excluded. The participants were provided with a patient information sheet prior to 
consenting to participate in the study. The researcher recruited 268 participants, of 
which thirty participants were randomly selected for face validity testing. All patients 
were recruited from a cardiology ward.  
The participants were invited to participate in the CSEQ translation process and 
consented to participate in the study. The questionnaire was distributed and collected 
on a cardiology ward once patients were haemodynamically stable. The participants 
completed the CSEQ independently. 
Ethical consideration 
Before beginning the data collection procedure, an ethical approval were obtained from 
JUH. In addition, a permission to use was granted from the CSEQ author. The 
researchers considered carefully the confidentiality, privacy and anonymity of the data 
during the data collection procedure. All participants were volunteered and had the right 
to withdrew from the study at any time and without giving any reasons. The data were 
kept in password-protected computer. The investigation conforms with the principles 
outlined in the Declaration of Helsinki (Declaration of Helsinki, 1964).  
Data analysis 
The researchers used SPSS version 24.0 to analyse the collected data. The skewness 
and kurtosis were used to determine the normality of CSEQ. Descriptive statistics, such 
as mean and standard deviation (SD), were used to describe the participants’ 
characteristics. In addition, internal consistency and factor structure of the Arabic 




Before receiving the completed questionnaires, we checked that all questionnaires from 
the respondents had been completed; consequently, there was no missing data. 
Completion of the CSEQ took approximately 10-15 minutes. 
Participants’ characteristics 
Following the process outlined by the WHO, for the translation and adaptation of 
instruments. A total sample of 268 participants, diagnosed with CHD, were recruited 
from the JUH in Amman, Jordan. The sample included 166 males (61.8 %) and 102 
females (38.1 %). The mean age of the respondents was 57 years of age and ranged 
from 38 to 82 years of age. The age of respondents was normally distributed. There 
was no difference in age according to gender (Males X=56.10 Females=57.55). Over 
60% of the sample were married and more than half (63%) were in employment. 
Overall, there was a good spread across demographic characteristics. There was no 
significant difference in age according to gender, Table 2. Mean scores of CSEQ 
ranged from 1.88 – 2.32 and represent a central tendency from somewhat confident 
towards moderate confidence. There were no issues of skewness and kurtosis across 
the 16 items. 
Please insert Table 2 here  
Validity:  
The researcher decided to test the face validity of the Arabic version of the 
questionnaire with 30 patients (Beaton et al., 2000). Each patient completing the 
questionnaire; was asked for their understanding of the meaning of each item in CSEQ 
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questionnaire, problems with the questionnaire format and alternative response scale. 
Difficulties or suggestive comments were discussed, documented and included in the 
final report.  
The researchers wrote detailed comments, including suggested alternatives to the 
Arabic CSEQ version which were then forwarded to the expert panel. The participants 
expressed their satisfaction with the transparency of the CSEQ and the ease of its 
completion. The researcher asked participants whether they had any comments or 
suggestions that could make the questionnaire more comprehensible. More than two 
third of participants (21 participants) expressed their satisfaction and no improvements 
were suggested. Five participants suggested modifying the alternating scoring system 
and add numbers for each choice. Two participants suggested changing the colour to 
separate each section and make the questions in bold font and two participants 
suggested to changes the initial words in questions number 8 and 13. All comments 
were considered and required amendments were conducted.  
The content validity of the Arabic versions of the CSEQ was evaluated by an expert 
panel from the faculty of nursing at the Applied Science Private University, Amman, 
Jordan. The experts rated each item to calculate CVI according to the four-point rating 
score 1= not relevant, 2= somewhat relevant, 3= quite relevant, 4= highly relevant. The 
CVI was calculated based on the number of experts that rated the item’s relevance at 
either three or four on the scale. The Scale-level Content Validity Index (S-CVI), is 
accepted if CVI > 0.80 (Polit & Beck, 2014). The CVI for the Arabic CSEQ version was 
found to be 1.0 which shows a very good level of content validity (Polit & Beck, 2014). 
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Exploratory factor analysis  
Examination of the correlation matrix shows three issues of collinearity as indicated by a 
correlation score above 0.8.  All relationships were positive and the majority were low to 
moderate strength indicating diversity in measurement, Table 3. 
The 16-items were tested using maximum likelihood extraction and with a varimax 
rotation in order to provide as clear a factor structure as possible.  A three-factor model 
emerged from the analysis, Table 4. This represented 70% of the total variance. Factor 
1 – control of symptoms represented 40% (eigenvalue 6.445) and factor loading ranged 
from 0.627 - .846.  Factor 2 – Maintaining functioning - represented 17% of the total 
variance and had an eigenvalue of 2.651; factor 3 – behaviour change, represented 
13% of the total variance and had an eigenvalue of 2.139. 
Please insert table 3  
Please insert table 4  
 
The reliability of the three individual subscales of the CSEQ ranged from 0.89 to 0.93. 
For the first subscale, which focuses on controlling symptoms (8 items), the reliability 
was 0.89. For the second subscale, which considers the maintenance function (5 
items), the score was found to be 0.92 and for the third subscale, which comprises three 
items related to a healthy lifestyle, the score was calculated as 0.93 (Table 5). The 
Cronbach’s alpha score for the Arabic version of the CSEQ was 0.90. Mean scores of 
constructs show that participants were most confident in looking after their symptoms 
relating to cardiac care and least confident about lifestyle.   




The global burden of CVDs is increasing year on year (Fuster, 2014), and secondary 
prevention strategies that encourage the adoption of healthy lifestyles are highly 
recommended to reduce this risk (WHO, 2015). According to Bandura’s self-efficacy 
theory, patients with higher self-efficacy levels have a great capability of adopting such 
lifestyles (Bandura, 1997) which in turn highlights the importance of measuring and 
attempting to increase levels of self-efficacy as part of secondary prevention strategies 
(Katch, 2010; Sol et al., 2011). However, there has not been, until now, a valid and 
reliable instrument that is capable of measuring self-efficacy in Middle Eastern 
populations. The CSEQ is a disease specific self-efficacy questionnaire that measures 
self-efficacy among cardiac patients but this tool has not been available in Arabic. In 
order to address this need we have successfully translated and cross-culturally adapted 
the original version of the CSEQ into Arabic. This process was undertaken in line with 
the WHO process of instrument translation and cultural adaptation and Wild et al. 
(2005) guidelines and standards for the translation and cultural adaptation as paper 
framework.  
Contextual meaning is closely linked to language. Without the careful translation of 
items, participants may have misunderstood their correct meaning. In addition, the 
social and cultural differences between Western and Arabic countries are also a cause 
for concern, particularly reflected in discussions around sexual relationships in the 
original CSEQ, a topic that is not normally discussed in Arabic-speaking countries. 
Therefore, the WHO process of translation and cultural adaptation of instruments was 
crucial to ensure accurate conceptual understanding of items 
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All items in the CSEQ were accurately translated and culturally adapted into Arabic. 
During implementation of piloting, the acceptability of the Arabic version of the CSEQ 
was excellent, with no items considered confusing and no questions considered 
disturbing. There were no particular problems in the questionnaire translation process.  
Face validity testing showed that the appearance of the CSEQ, the writing style, format 
and language of items were all clear. The content validity revealed that there was good 
content relevance of the CSEQ (CVI =1.0). The internal consistency of the translated 
version is an excellent (0.90). In addition, the three CSEQ subscales have close internal 
consistency with each other. The psychometric properties of the Arabic CSEQ 
demonstrates that it is a valid and reliable instrument. 
 The reliability was high for all the CSEQ’s subscales in this study, with reliability 
ranging from 0.89 to 0.93, demonstrating an excellent stability for the CSEQ over time. 
These results are similar to findings in studies completed in other languages under 
similar circumstances (Fors, Ulin, Cliffordson, Ekman, & Brink, 2014; Kang & Yang, 
2013; Saengsiri et al., 2013; Zhang et al., 2018), including the original study (Sullivan et 
al., 1998).   
As has been stated above, measuring self-efficacy and addressing low levels of self-
efficacy is a key to the promotion of self-management practices. We believe that the 
translation and cross-cultural adaptation of the CSEQ into Arabic now allows this 
practice to occur in Middle Eastern populations.  
CVD risk factors are markedly increased in Middle Eastern countries (Afshin et al., 
2015). Improving self-efficacy has many beneficial outcomes and is essential to healthy 
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lifestyle changes for cardiac patients (Fors, Ekman, et al., 2015; Köhler et al., 2018; 
Salari et al., 2016). Therefore, the need for an Arabic CSEQ to address the gap in 
knowledge related to self-efficacy in Arabic patients is highly warranted. In addition, 
measurements of Arabic CSEQ will help nurses to support cardiac patients to reduce 
coronary risk and adopt healthier lifestyles, which in turn will hopefully decrease the 
burden of CVD in Middle Eastern countries. Moreover, using Modern Standard Arabic 
(Fusha) in the current study during the translation and cross-cultural adaptation process 
will make the CSEQ more broadly applicable for a range of cardiac patients in Middle 
Eastern countries. 
Limitations of the Study: 
 The Arabic CSEQ was administered solely, to people diagnosed with CHD, thus these 
findings cannot yet be generalized to other cardiac populations such as those with heart 
failure and arrhythmias. Therefore, we recommend that the Arabic version of the CSEQ 
should be tested in patients from a wider cardiac population. 
 CONCLUSION 
The CSEQ was successfully translated and cross-culturally adapted into Arabic using 
the WHO process of translation and cultural adaptation and Wild et al. (2005) as paper 
framework. The Arabic version of the CSEQ was found to possess good levels of face 
and content validity, internal consistency and reliability. We therefore suggest that the 
Arabic version of the CSEQ be introduced into clinical practice as a means of 
measuring self-efficacy in Arabic speaking patients to evaluate cardiac self-efficacy and 
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to improve self-management skills of patients with CHD in Arabic speaking countries. In 
addition, measuring the self-efficacy levels using the Arabic version of CSEQ, can 
facilitate secondary prevention intervention measures and developing cardiac 
rehabilitation program in the Middle Eastern counties. Further, using of the Arabic 
version of the cardiac self-efficacy questionnaire can be very helpful in future research, 
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Table 1: Comparison of the original English items and back translated ones: 
Item  
No  
Original English Items 
 
 












How confident are you that you 
know or can 
How are you confident that you know: 
1 Control your chest pain by 
changing your activity levels 
Control of chest pain by changing your 
activity levels. 
2 Control your breathlessness by 
changing your activity levels 
Control of your difficult breathing by 
changing your physical activity. 
3 Control your chest pain by taking 
your medications 
Control your chest pain by using own 
medications. 
4 Control your breathlessness by 
taking your medications 
Control of difficulty breathing by having 
own medicine. 
5 When you should call or visit your 
doctor about your heart disease 
When you are calling or visiting your 
doctor about heart disease. 
6 How to make your doctor 
understand your concerns about 
your heart 
How to make your doctor understand your 
fears about your heart disease. 
7 How to take your cardiac 
medications 
How to take your heart medications. 
8 How much physical activity is good 
for your health 
How much of physical activity improves 













How much confident to  How much you are confident to 
9 Maintain your usual social activities Maintain your usual social activities. 
10 Maintain your usual activities at 
home with your family 
Maintain your usual activities with your 
family at home. 
11 Maintain your usual activities at 
work 
Maintain your usual activities at work. 
12 Maintain your sexual relationship 
with your spouse 
Maintain your sexual relationship with your 
spouse. 
13 Get regular aerobic exercise (work 
up a sweat and increase your heart 
rate) 
Get regular exercises (working until 











How much is good for you to do : 
 
How much is good for yourself to do: 
14 Lose weight (if you are overweight)  Reduce your weight (if you are obese) 
15 Stop smoking (if you do smoke) Stop smoking (if you are a smoker) 
16 Change your diet (if your doctor 
recommended this)  
Changing your diet (if your doctor 
recommended that) 
 Alternative score  
1 Not at all confident Not confident 
2 Somewhat confident Confident fairly 
3 Moderately confident Moderately  confident  
4 Very confident High confident 
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 Characteristics Frequency Mean 
 









2 Education level 










































Table 3.  Correlation matrix of 16-items of Cardiac Self-efficacy Scale 












CSE1 1               
CSE2 .84 1              
CSE3 .41 .49 1             
CSE4 .42 .55 .72 1            
CSE5 .41 .47 .49 .42 1           
CSE6 .55 .65 .51 .57 .79 1          
CSE7 .50 .51 .35 .44 .40 .53 1         
CSE8 .43 .47 .41 .49 .38 .54 .77 1        
CSE9 .34 .40 .55 .39 .25 .31 .27 .27 1       
CSE10 .32 .39 .35 .32 .17 .25 .19 .17 .77 1      
CSE11 .52 .46 .22 ,21 .17 .28 .30 .25 .58 ,69 1     
CSE12 .47 .53 .20 .24 .16 .27 .24 .21 .62 .75 .89 1    
CSE13 .28 .32 .48 .34 .20 .24 .19 .24 .79 .74 .62 .66 1   
CSE14 .14 .11 .17 .09 .09 .08 .08 .09 .21 .16 .23 .19 .28 1  
CSE15 .20 .14 .21 .11 .14 .10 .12 .13 .22 .19 .24 .20 .29 .75 1 












Table 4.  Factor Structure of Cardiac Self-efficacy Scale  
 Cardiac Self-efficacy Questionnaire items 1 2 3 
CSE1 Control your chest pain by changing your activity 
levels 
.627   
CSE2 Control your breathlessness by changing your 
activity levels 
.710   
CSE3 Control your chest pain by taking your medications .643   
CSE4 Control your breathlessness by taking your 
medications 
.685   
CSE5 When you should call or visit your doctor about 
your heart disease 
.731   
CSE6 How to make your doctor understand your concerns 
about your heart 
.846   
CSE7 How to take your cardiac medications .642   
CSE8 How much physical activity is good for you .648   
CSE9 Maintain your usual social activities  .649  
CSE10 Maintain your usual activities at home with your 
Family 
 .789  
CSE11 Maintain your usual activities at work  .877  
CSE12 Maintain your sexual relationship with your 
Spouse 
 .938  
CSE13 Get regular aerobic exercise (work up a sweat 
and increase your heart rate) 
 .693  
CSE14 Lose weight (if you are overweight)   .959 
CSE15 Stop smoking (if you do smoke)   .753 
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CSE16 Changing your diet (if your doctor recommended 
that). 


























Table 5: CSEQ subscales reliability.  
CSEQ  
Subscales  
Range  Cronbach’s 
alpha   




part (8 items) 
0-32 0.89 
























Figure 1: The WHO process of cross-cultural adaptation of the CSEQ 

























Figure 2: Translation and cultural adaptation process of the Cardiac Self-Efficacy 
Questionnaire. 
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